M. Asakura, M. Kitakaze, S. Takashima, Y. Liao, F. Ishikura et al., Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy, Nature Medicine, vol.8, issue.1, pp.35-40, 2002.
DOI : 10.1038/nm0102-35

R. Black, C. Rauch, C. Kozlosky, J. Peschon, J. Slack et al., A metalloproteinase disintegrin that releases tumour-necrosis factor-?? from cells, Nature, vol.385, issue.6618, pp.729-733, 1997.
DOI : 10.1038/385729a0

R. Bonfil, R. Reddel, H. Ura, R. Reich, R. Fridman et al., Invasive and Metastatic Potential of a v-Ha-ras-Transformed Human Bronchial Epithelial Cell Line, JNCI Journal of the National Cancer Institute, vol.81, issue.8, pp.587-594, 1989.
DOI : 10.1093/jnci/81.8.587

S. Cal, A. Obaya, M. Llamazares, C. Garabaya, V. Quesada et al., Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains, Gene, vol.283, issue.1-2, pp.49-62, 2002.
DOI : 10.1016/S0378-1119(01)00861-7

D. Cataldo, K. Tournoy, K. Vermaelen, C. Munaut, J. Foidart et al., Matrix Metalloproteinase-9 Deficiency Impairs Cellular Infiltration and Bronchial Hyperresponsiveness during Allergen-Induced Airway Inflammation, The American Journal of Pathology, vol.161, issue.2, pp.491-498, 2002.
DOI : 10.1016/S0002-9440(10)64205-8
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1850735

J. Dunn, D. Panutsopulos, M. Shaw, J. Heighway, R. Dormer et al., METH-2 silencing and promoter hypermethylation in NSCLC, British Journal of Cancer, vol.274, pp.1149-1154, 2004.
DOI : 10.1038/sj.bjc.6602107

M. Egeblad and Z. Werb, New functions for the matrix metalloproteinases in cancer progression, Nature Reviews Cancer, vol.78, issue.3, pp.161-174, 2002.
DOI : 10.1038/nrc745

B. Gilpin, F. Loechel, M. Mattei, E. Engvall, R. Albrechtsen et al., A Novel, Secreted Form of Human ADAM 12 (Meltrin ??) Provokes Myogenesis in Vivo, Journal of Biological Chemistry, vol.273, issue.1, pp.157-166, 1998.
DOI : 10.1074/jbc.273.1.157

A. Hajitou, N. Sounni, L. Devy, C. Grignet-debrus, J. Lewalle et al., Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis, Cancer Res, vol.61, pp.3450-3457, 2001.

M. Handsley and D. Edwards, Metalloproteinases and their inhibitors in tumor angiogenesis, International Journal of Cancer, vol.161, issue.6, pp.849-860, 2005.
DOI : 10.1002/ijc.20945

K. Horiuchi, G. Weskamp, L. Lum, H. Hammes, H. Cai et al., Potential Role for ADAM15 in Pathological Neovascularization in Mice, Molecular and Cellular Biology, vol.23, issue.16, pp.5614-5624, 2003.
DOI : 10.1128/MCB.23.16.5614-5624.2003

K. Iba, R. Albrechtsen, B. Gilpin, C. Frohlich, F. Loechel et al., The Cysteine-Rich Domain of Human Adam 12 Supports Cell Adhesion through Syndecans and Triggers Signaling Events That Lead to ??1 Integrin???Dependent Cell Spreading, The Journal of Cell Biology, vol.13, issue.5, pp.1143-1156, 2000.
DOI : 10.1006/excr.1999.4632

M. Iruela-arispe, D. Carpizo, and A. Luque, ADAMTS1: A Matrix Metalloprotease with Angioinhibitory Properties, Annals of the New York Academy of Sciences, vol.105, issue.Suppl. 1, pp.183-190, 2003.
DOI : 10.1111/j.1749-6632.2003.tb03221.x

N. Ishikawa, Y. Daigo, W. Yasui, K. Inai, H. Nishimura et al., ADAM8 as a Novel Serological and Histochemical Marker for Lung Cancer, Clinical Cancer Research, vol.10, issue.24, pp.8363-8370, 2004.
DOI : 10.1158/1078-0432.CCR-04-1436

A. Iwasaki, M. Kuwahara, Y. Yoshinaga, and T. Shirakusa, Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC, European Journal of Cardio-Thoracic Surgery, vol.25, issue.3, pp.443-448, 2004.
DOI : 10.1016/j.ejcts.2003.11.031

G. Kaushal and S. Shah, The new kids on the block: ADAMTSs, potentially multifunctional metalloproteinases of the ADAM family, Journal of Clinical Investigation, vol.105, issue.10, pp.1335-1337, 2000.
DOI : 10.1172/JCI10078

L. Killar, J. White, R. Black, and J. Peschon, Adamalysins: A Family of Metzincins Including TNF-alpha Converting Enzyme (TACE), Annals of the New York Academy of Sciences, vol.269, issue.1 INHIBITION OF, pp.442-452, 1999.
DOI : 10.1038/376337a0

K. Kuno, N. Kanada, E. Nakashima, F. Fujiki, F. Ichimura et al., Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene, J Biol Chem, vol.272, pp.556-562, 1997.

H. Lemjabbar, D. Li, M. Gallup, S. Sidhu, E. Drori et al., Tobacco Smoke-induced Lung Cell Proliferation Mediated by Tumor Necrosis Factor ??-converting Enzyme and Amphiregulin, Journal of Biological Chemistry, vol.278, issue.28, pp.26202-26207, 2003.
DOI : 10.1074/jbc.M207018200

L. Pabic, H. Bonnier, D. Wewer, U. Coutand, A. Musso et al., ADAM12 in human liver cancers: TGF-??-regulated expression in stellate cells is associated with matrix remodeling, Hepatology, vol.278, issue.5, pp.1056-1066, 2003.
DOI : 10.1053/jhep.2003.50205

A. Luque, D. Carpizo, and M. Iruela-arispe, ADAMTS1/METH1 Inhibits Endothelial Cell Proliferation by Direct Binding and Sequestration of VEGF165, Journal of Biological Chemistry, vol.278, issue.26, pp.23656-23665, 2003.
DOI : 10.1074/jbc.M212964200

E. Maquoi, N. Sounni, L. Devy, F. Olivier, F. Frankenne et al., Anti-Invasive, Antitumoral, and Antiangiogenic Efficacy of a Pyrimidine-2,4,6-trione Derivative, an Orally Active and Selective Matrix Metalloproteinases Inhibitor, Clinical Cancer Research, vol.10, issue.12, pp.4038-4047, 2004.
DOI : 10.1158/1078-0432.CCR-04-0125

T. Masui, R. Hosotani, S. Tsuji, Y. Miyamoto, S. Yasuda et al., Expression of METH-1 and METH-2 in pancreatic cancer, Clin Cancer Res, vol.7, pp.3437-3443, 2001.

N. Mckie, T. Edwards, D. Dallas, A. Houghton, B. Stringer et al., Expression of Members of a Novel Membrane Linked Metalloproteinase Family (ADAM) in Human Articular Chondrocytes, Biochemical and Biophysical Research Communications, vol.230, issue.2, pp.335-339, 1997.
DOI : 10.1006/bbrc.1996.5957

M. Moss, J. White, M. Lambert, and R. Andrews, TACE and other ADAM proteases as targets for drug discovery, Drug Discovery Today, vol.6, issue.8, pp.417-426, 2001.
DOI : 10.1016/S1359-6446(01)01738-X

C. Munaut, A. Noel, O. Hougrand, J. Foidart, J. Boniver et al., Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas, International Journal of Cancer, vol.72, issue.6, pp.848-855, 2003.
DOI : 10.1002/ijc.11313

A. Noel, C. Maillard, N. Rocks, M. Jost, V. Chabottaux et al., Membrane associated proteases and their inhibitors in tumour angiogenesis, Journal of Clinical Pathology, vol.57, issue.6, pp.577-584, 2004.
DOI : 10.1136/jcp.2003.014472

C. Overall and C. Lopez-otin, Strategies for mmp inhibition in cancer: innovations for the post-trial era, Nature Reviews Cancer, vol.2, issue.9, pp.657-672, 2002.
DOI : 10.1038/nrc884

S. Porter, I. Clark, L. Kevorkian, and D. Edwards, The ADAMTS metalloproteinases, Biochemical Journal, vol.386, issue.1, pp.15-27, 2005.
DOI : 10.1042/BJ20040424

S. Porter, S. Scott, E. Sassoon, M. Williams, J. Jones et al., Dysregulated Expression of Adamalysin-Thrombospondin Genes in Human Breast Carcinoma, Clinical Cancer Research, vol.10, issue.7, pp.2429-2440, 2004.
DOI : 10.1158/1078-0432.CCR-0398-3

X. Puente, L. Sanchez, C. Overall, and C. Lopez-otin, Human and mouse proteases: a comparative genomic approach, Nature Reviews Genetics, vol.4, issue.7, pp.544-558, 2003.
DOI : 10.1038/nrg1111

M. Rosendahl, S. Ko, D. Long, M. Brewer, B. Rosenzweig et al., Identification and Characterization of a Pro-tumor Necrosis Factor-??-processing Enzyme from the ADAM Family of Zinc Metalloproteases, Journal of Biological Chemistry, vol.272, issue.39, pp.24588-24593, 1997.
DOI : 10.1074/jbc.272.39.24588

R. Roy, U. Wewer, D. Zurakowski, S. Pories, and M. Moses, ADAM 12 Cleaves Extracellular Matrix Proteins and Correlates with Cancer Status and Stage, Journal of Biological Chemistry, vol.279, issue.49, pp.51323-51330, 2004.
DOI : 10.1074/jbc.M409565200

N. Sounni, C. Roghi, V. Chabottaux, M. Janssen, C. Munaut et al., Up-regulation of Vascular Endothelial Growth Factor-A by Active Membrane-type 1 Matrix Metalloproteinase through Activation of Src-Tyrosine Kinases, Journal of Biological Chemistry, vol.279, issue.14, pp.13564-13574, 2004.
DOI : 10.1074/jbc.M307688200

B. Tang, ADAMTS: a novel family of extracellular matrix proteases, The International Journal of Biochemistry & Cell Biology, vol.33, issue.1, pp.33-44, 2001.
DOI : 10.1016/S1357-2725(00)00061-3

Y. Trejo, R. Bordenave, M. Beviacqua, L. Zanoni, and L. Rumi, Tumor necrosis factor-alfa production by monocytes from lung and colorectal cancer patients, J Exp Clin Cancer Res, vol.20, pp.71-73, 2001.

Z. Werb, T. Vu, J. Rinkenberger, and L. Coussens, Matrix-degrading proteases and angiogenesis during development and tumor formation, APMIS, vol.15, issue.Suppl. 2, pp.11-18, 1999.
DOI : 10.1111/j.1699-0463.1999.tb01521.x

E. Wu, P. Croucher, and N. Mckie, Expression of Members of the Novel Membrane Linked Metalloproteinase Family ADAM in Cells Derived from a Range of Haematological Malignancies, Biochemical and Biophysical Research Communications, vol.235, issue.2, pp.437-442, 1997.
DOI : 10.1006/bbrc.1997.6714

A. Zolkiewska, Disintegrin-like/Cysteine-Rich Region of ADAM 12 Is an Active Cell Adhesion Domain, Experimental Cell Research, vol.252, issue.2, pp.423-431, 1999.
DOI : 10.1006/excr.1999.4632